hydrochlorothiazide has been researched along with Anxiety in 4 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 9.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 5.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "Hypertension is also related to poor performance in tests that assess cognitive functions." | 1.37 | The influence of cognition, anxiety and psychiatric disorders over treatment adherence in uncontrolled hypertensive patients. ( De Castro, MS; Ferreira, MB; Fuchs, FD; Jacobs, Ú, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, Ú | 1 |
| De Castro, MS | 1 |
| Fuchs, FD | 1 |
| Ferreira, MB | 1 |
| Nedostup, AV | 1 |
| Fedorova, VI | 1 |
| Linevich, AIu | 1 |
| Pukhal'skaia, TG | 1 |
| Toropina, GG | 1 |
| Kudrin, VS | 1 |
| Klodt, PM | 1 |
| Ebel, H | 1 |
| Lübke, H | 1 |
| Klaus, D | 1 |
| Zehner, J | 1 |
| Witzgall, H | 1 |
| Milkovich, L | 1 |
| van den Berg, BJ | 1 |
2 trials available for hydrochlorothiazide and Anxiety
| Article | Year |
|---|---|
[Anxiodepressive and neuromediatory disorders in hypertensive patients. Effects of cypramil therapy].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Anxiety; Citalopram; | 2005 |
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
Topics: Anxiety; Bradycardia; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydroch | 1978 |
2 other studies available for hydrochlorothiazide and Anxiety
| Article | Year |
|---|---|
The influence of cognition, anxiety and psychiatric disorders over treatment adherence in uncontrolled hypertensive patients.
Topics: Aged; Antihypertensive Agents; Anxiety; Cognition; Cohort Studies; Female; Humans; Hydrochlorothiazi | 2011 |
Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development.
Topics: Abnormalities, Drug-Induced; Aluminum; Anxiety; Child, Preschool; Chlordiazepoxide; Embryo, Mammalia | 1974 |